levodopa has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caetano, A; Meira, B; Pinto, M; Roque, R | 1 |
| Cai, H; Matsubara, S; Mukai, M; Nakano, I; Sasaki, H; Sugaya, K; Yabe, I | 1 |
| Harper, JW; Hoekstra, JG; Huang, CH; Kennedy, SR; Ordureau, A; Pickrell, AM; Sideris, DP; Youle, RJ | 1 |
| Artuch, R; Briones, P; Carrilho, I; Duarte, S; Garcia-Cazorla, A; Garesse, R; Montoya, J; Nascimento, A; Ormazabal, A; Pineda, M; Sala-Castellvi, P; Serrano, M | 1 |
| Ekstrand, MI; Galter, D | 1 |
| Albanese, A; Bellacchio, E; Dallapiccola, B; Elia, AE; Romito, LM; Valente, EM | 1 |
| Asanuma, M; Diaz-Corrales, FJ; Miyazaki, I; Miyoshi, K; Ogawa, N | 1 |
| Finsterer, J | 1 |
3 review(s) available for levodopa and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
[Familial progressive external opthalmoplegia, parkinsonism and polyneuropathy associated with POLG1 mutation].
Topics: Aged; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Female; Gene Deletion; Genes, Dominant; Humans; Levodopa; Male; Menopause, Premature; Mitochondrial Diseases; Muscular Diseases; Mutation; Ophthalmoplegia, Chronic Progressive External; Parkinsonian Disorders; Pedigree; Polyneuropathies; Syndrome | 2014 |
The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
Topics: Animals; Antiparkinson Agents; Disease Models, Animal; DNA-Binding Proteins; Dopamine; Electron Transport; Humans; Levodopa; Mice; Mice, Transgenic; Mitochondrial Diseases; Mitochondrial Proteins; Neurons; Parkinson Disease; Transcription Factors | 2009 |
L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease.
Topics: Animals; Cell Death; Dopamine; Humans; Levodopa; Mitochondrial Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders | 2005 |
5 other study(ies) available for levodopa and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
Late-onset presentation of POLG1-associated mitochondrial disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Blepharoptosis; Disease Progression; DNA Polymerase gamma; Humans; Levodopa; Male; Mitochondrial Diseases; Ophthalmoplegia, Chronic Progressive External; Parkinsonian Disorders; Point Mutation; Treatment Outcome | 2019 |
Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
Topics: Analysis of Variance; Animals; DNA, Mitochondrial; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Gene Expression Regulation; Green Fluorescent Proteins; In Vitro Techniques; Levodopa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondrial Diseases; Multienzyme Complexes; Mutation; Proteomics; Substantia Nigra; Tyrosine 3-Monooxygenase; Ubiquitin; Ubiquitin-Protein Ligases | 2015 |
Mitochondrial diseases mimicking neurotransmitter defects.
Topics: Alanine; Brain; Child, Preschool; Consanguinity; Diagnosis, Differential; Dopamine Agents; Dystonia; Electron Transport Complex I; Electron Transport Complex II; Electron Transport Complex III; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Infant, Newborn; Lactic Acid; Levodopa; Male; Mitochondrial Diseases; Neurotransmitter Agents; Pterins; Radiography; Treatment Outcome | 2008 |
The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease.
Topics: Age of Onset; Brain; Diagnosis, Differential; Dopamine Agents; Energy Metabolism; Genetic Predisposition to Disease; Humans; Italy; Levodopa; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Mutation; Parkinson Disease; Parkinsonian Disorders; Phenotype; Protein Kinases; Shy-Drager Syndrome; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
Parkinson syndrome as a manifestation of mitochondriopathy.
Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Biopsy; DNA, Mitochondrial; Dopamine; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Mitochondrial Diseases; Muscle, Skeletal; Oxidative Phosphorylation; Parkinsonian Disorders; Point Mutation; Severity of Illness Index | 2002 |